The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivo studies
Open accessAbstract
The potency, duration of action and tolerability of Hoe 140, a novel and highly potent bradykinin (BK) antagonist in vitro, has been tested in different in vivo models and compared with the well‐known BK antagonist d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK. Hoe 140 is highly potent and long acting in inhibiting BK‐induced hypotensive responses in the rat. Four hours after s.c. administration of 20 nmol kg−1, inhibition still amounted to 60% whereas the effect of 200 nmol kg−1 of d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK was not significant. BK‐induced bronchoconstriction in guinea‐pigs was strongly inhibited by Hoe 140. The magnitude and duration of inhibition confirmed the findings obtained in the blood pressure experiments in the rat. Carrageenin‐induced inflammatory oedema of the rat paw was considerably inhibited at i.v. doses between 0.1 and 1 mg kg−1. In conscious dogs, intravenous doses of 0.01 and 0.1 mg kg−1 of Hoe 140 and d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK were well tolerated. At doses of 1 mg kg−1 adverse effects occurred that were attributed to the residual BK agonistic activity of both compounds. Hoe 140 has been shown to be a highly potent and long acting BK antagonist in vivo in different animal species and models. This makes it appropriate to investigate further the physiological and pathophysiological role of BK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs
Winter, C. A., Risley, E. A., & Nuss, G. W. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-111-27849 · Cited by 5,688
Tsien, R. Y., Pozzan, T., & Rink, T. J. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.2.325 · Cited by 2,244
Pharmacology of bradykinin and related kinins.
Regoli, D., & Barabé, J. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06836-x · Cited by 1,892
Sachs, L. (1984) · Springer eBooks · doi:10.1007/978-3-662-05748-3 · Cited by 638
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies
Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12248.x · Cited by 613
Self-citationCompetitive antagonists of bradykinin
Vavrek, R. J., & Stewart, J. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90033-6 · Cited by 463
Kinin Formation: Mechanisms and Role in Inflammatory Disorders
Proud, D., & Kaplan, A. P. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.000405 · Cited by 410
Steranka, L. R., Manning, D. C., DeHaas, C. J., Ferkany, J. W., Borosky, S. A., Connor, J. R., Vavrek, R. J., Stewart, J. M., & Snyder, S. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3245 · Cited by 400
Cited by
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Mundel, P., Reiser, J., Borja, A. Z. M., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 877
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Kinin receptors in pain and inflammation
Couture, R., Harrisson, M., Vianna, R. M., & Cloutier, F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01318-8 · Cited by 472
Metadata
- Authors
- Wirth, K., Hock, F. J., Albus, U., Linz, W., Alpermann, H. G., Anagnostopoulos, H., Henke, S., Breipohl, G., König, W., Knolle, J., & Schölkens, B. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1991-03
- Volume
- 102
- Issue
- 3
- Pages
- 774-777
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1974146850
- Cited by
- 830
- References
- 19
- FWCI
- 43.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivo studies. https://app.cochat.ai/papers/10.1111/j.1476-5381.1991.tb12249.x
- The paper
- Wirth, K., Hock, F. J., Albus, U., Linz, W., Alpermann, H. G., Anagnostopoulos, H., Henke, S., Breipohl, G., König, W., Knolle, J., & Schölkens, B. A. (1991). Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivo studies. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1991.tb12249.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.